These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23957698)
1. Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillary thyroid cancer. Kwon KH; Lee YC; Chung JH; Eun YG J Invest Surg; 2013 Dec; 26(6):319-24. PubMed ID: 23957698 [TBL] [Abstract][Full Text] [Related]
2. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population. Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075 [TBL] [Abstract][Full Text] [Related]
4. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population. Park SW; Kim MK; Kwon KH; Kim J Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576 [TBL] [Abstract][Full Text] [Related]
5. A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer. Eun YG; Chung DH; Kim SW; Lee YC; Kim SK; Kwon KH Eur Surg Res; 2014; 52(1-2):1-7. PubMed ID: 24434721 [TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer. Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544 [TBL] [Abstract][Full Text] [Related]
7. Association Between Genetic Polymorphisms in the Promoter Regions of Let-7 and Risk of Papillary Thyroid Carcinoma: A Case-Control Study. Wang Y; Wei T; Xiong J; Chen P; Wang X; Zhang L; Gao L; Zhu J Medicine (Baltimore); 2015 Oct; 94(43):e1879. PubMed ID: 26512603 [TBL] [Abstract][Full Text] [Related]
8. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population. Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616 [TBL] [Abstract][Full Text] [Related]
9. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility. Dong G; Zhang R; Xu J; Guo Y Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556 [TBL] [Abstract][Full Text] [Related]
10. PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer. Kim MJ; Kim SK; Park HJ; Chung DH; Park HK; Lee JS; Kwon KH; Chung JH Mol Med Rep; 2012 May; 5(5):1267-70. PubMed ID: 22327316 [TBL] [Abstract][Full Text] [Related]
11. Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer. Eun YG; Kim SK; Chung JH; Kwon KH Am J Surg; 2013 Jun; 205(6):631-5. PubMed ID: 23388428 [TBL] [Abstract][Full Text] [Related]
12. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population. Wei WJ; Lu ZW; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH Int J Mol Sci; 2014 Nov; 15(11):20968-81. PubMed ID: 25405731 [TBL] [Abstract][Full Text] [Related]
13. Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population. Kim MK; Park SW; Kim SK; Park HJ; Eun YG; Kwon KH; Kim J J Korean Med Sci; 2012 Nov; 27(11):1333-8. PubMed ID: 23166414 [TBL] [Abstract][Full Text] [Related]
14. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China? Ai L; Yu Y; Liu X; Wang C; Shi J; Sun H; Yu Q Front Med; 2014 Mar; 8(1):113-7. PubMed ID: 24452548 [TBL] [Abstract][Full Text] [Related]
15. A genetic association analysis of polymorphisms, rs2282695 and rs12373539, in the FOSB gene and papillary thyroid cancer. Han SA; Song JY; Min SY; Park WS; Kim MJ; Chung JH; Kwon KH Exp Ther Med; 2012 Sep; 4(3):519-523. PubMed ID: 23181129 [TBL] [Abstract][Full Text] [Related]
16. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population. Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140 [TBL] [Abstract][Full Text] [Related]
17. Polymorphism of IGF1R is associated with papillary thyroid carcinoma in a Korean population. Cho SH; Kim SK; Kwon E; Park HJ; Kwon KH; Chung JH J Interferon Cytokine Res; 2012 Sep; 32(9):401-6. PubMed ID: 22909219 [TBL] [Abstract][Full Text] [Related]
18. Association between single-nucleotide polymorphisms of BRAF and papillary thyroid carcinoma in a Chinese population. Zhang Q; Song F; Zheng H; Zhu X; Song F; Yao X; Zhang L; Chen K Thyroid; 2013 Jan; 23(1):38-44. PubMed ID: 22973979 [TBL] [Abstract][Full Text] [Related]
19. Association Study of FOS-Like Antigen-2 Promoter Polymorphisms With Papillary Thyroid Cancer in Korean Population. Kim SW; Kim CD; Chung JH; Kwon KH Clin Exp Otorhinolaryngol; 2014 Mar; 7(1):42-6. PubMed ID: 24587880 [TBL] [Abstract][Full Text] [Related]
20. Association of the oncostatin m receptor gene polymorphisms with papillary thyroid cancer in the korean population. Hong IK; Eun YG; Chung DH; Kwon KH; Kim DY Clin Exp Otorhinolaryngol; 2011 Dec; 4(4):193-8. PubMed ID: 22232715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]